Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M132,756Revenue (TTM) $M16,380Net Margin (%)31.3Altman Z-Score15.6
Enterprise Value $M134,669EPS (TTM) $2.0Operating Margin %43.6Piotroski F-Score7
P/E(ttm)25.7Beneish M-Score-2.4Pre-tax Margin (%)39.1Higher ROA y-yN
Price/Book24.110-y EBITDA Growth Rate %19.2Quick Ratio0.8Cash flow > EarningsY
Price/Sales8.15-y EBITDA Growth Rate %18.8Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow25.5y-y EBITDA Growth Rate %5.1ROA % (ttm)41.2Higher Current Ratio y-yY
Dividend Yield %1.9PEG1.4ROE % (ttm)86.7Less Shares Outstanding y-yY
Payout Ratio %47.0Shares Outstanding M2,600ROIC % (ttm)141Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVOKen Fisher 2016-03-31 Reduce-0.03%USD 46.58 - USD 58.08
(USD 53.57)
USD 51.06-5%Reduce -2.35%11,178,809
NVORuane Cunniff 2016-03-31 Add0.01%USD 46.58 - USD 58.08
(USD 53.57)
USD 51.06-5%Add 19.93%97,525
NVOMario Gabelli 2016-03-31 AddUSD 46.58 - USD 58.08
(USD 53.57)
USD 51.06-5%Add 0.24%6,225
NVOKen Fisher 2015-12-31 Reduce-0.02%USD 52.93 - USD 58.77
(USD 55.36)
USD 51.06-8%Reduce -1.76%11,447,413
NVOMario Gabelli 2015-12-31 AddUSD 52.93 - USD 58.77
(USD 55.38)
USD 51.06-8%Add 0.65%6,210
NVOKen Fisher 2015-09-30 Reduce-0.07%USD 52.8 - USD 60.23
(USD 56.62)
USD 51.06-10%Reduce -5.23%11,652,268
NVORuane Cunniff 2015-09-30 ReduceUSD 52.8 - USD 60.23
(USD 56.62)
USD 51.06-10%Reduce -0.59%81,320
NVOMario Gabelli 2015-09-30 ReduceUSD 52.8 - USD 60.23
(USD 56.62)
USD 51.06-10%Reduce -5.73%6,170
NVOKen Fisher 2015-06-30 Reduce-0.04%USD 53.39 - USD 58.02
(USD 56.17)
USD 51.06-9%Reduce -2.88%12,295,864
NVOMario Gabelli 2015-06-30 ReduceUSD 53.39 - USD 58.02
(USD 56.17)
USD 51.06-9%Reduce -2.31%6,545
NVORuane Cunniff 2015-06-30 ReduceUSD 53.39 - USD 58.02
(USD 56.17)
USD 51.06-9%Reduce -0.30%81,800
NVOKen Fisher 2015-03-31 Reduce-0.03%USD 41.9 - USD 54.68
(USD 46.05)
USD 51.0611%Reduce -2.91%12,660,235
NVORuane Cunniff 2015-03-31 ReduceUSD 41.9 - USD 54.68
(USD 46.05)
USD 51.0611%Reduce -0.17%82,050
NVOMario Gabelli 2015-03-31 ReduceUSD 41.9 - USD 54.68
(USD 46.05)
USD 51.0611%Reduce -0.30%6,700
NVORuane Cunniff 2014-09-30 Reduce-0.02%USD 43.9 - USD 49.03
(USD 46)
USD 51.0611%Reduce -52.87%75,642
NVORuane Cunniff 2014-06-30 Reduce-0.02%USD 42.28 - USD 46.52
(USD 44.12)
USD 51.0616%Reduce -33.85%160,492
NVORuane Cunniff 2014-03-31 Reduce-0.01%USD 36.722 - USD 48.23
(USD 42.37)
USD 51.0621%Reduce -21.98%242,630
NVORuane Cunniff 2013-12-31 Add0.02%USD 32.72 - USD 36.95
(USD 34.88)
USD 51.0646%Add 58.71%310,970
NVOTom Gayner 2013-12-31 ReduceUSD 32.72 - USD 36.95
(USD 34.88)
USD 51.0646%Reduce -0.23%1,106,000
NVOKen Fisher 2013-12-31 AddUSD 32.72 - USD 36.95
(USD 34.88)
USD 51.0646%Add 0.29%13,553,935
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about NVO:

    News about NVO:

    Articles On GuruFocus.com
    High Yield, Strong Returns: Sturm Ruger, Nu Skin Enterprises Jun 23 2016 
    Stocks Mario Gabelli Has Bought for 2 Quarters Jun 20 2016 
    Jim Simons' Top Holdings Include VeriSign, Chipotle Dec 15 2015 
    Value Investing in BioPharma Nov 18 2015 
    Jim Simons' Five Most-Heavily Weighted Holdings Oct 21 2015 
    Ken Fisher Reduces Stake in Toyota, Increases Position in Anheuser-Busch Oct 20 2015 
    Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S Sep 14 2015 
    Nintai Returns: Q2 2015 Jul 01 2015 
    Leith Wheeler Investment Funds First Quarter 2015 Review Jun 15 2015 
    Jim Simons' Top 3 Positions and One That Doubled Return Jun 10 2015 

    More From Other Websites
    These 5 Stocks Could Be Toxic to Your Portfolio This Summer Jun 24 2016
    The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All Jun 22 2016
    Novo Nordisk A/S - aktietilbagekøbsprogram Jun 20 2016
    Novo Nordisk A/S - Share repurchase programme Jun 20 2016
    Why This Pharma Giant Lost $8 Billion in Market Cap This Week Jun 16 2016
    Novo Nordisk (NVO) Reports Positive Trial Results on Victoza Jun 15 2016
    Novo Nordisk Drug Cuts Diabetic Deaths, But Not Enough For Wall Street Jun 14 2016
    Can a Bunch of Doctors Keep an $8 Billion Secret? Not on Twitter Jun 14 2016
    Victoza® significantly reduced the risk of major cardiovascular events and death in adults with... Jun 14 2016
    Novo diabetes drug cuts heart risks by 13 pct in trial Jun 14 2016
    Study Finds Victoza® Significantly Reduced the Risk of Heart Attack and Stroke in People with Type... Jun 13 2016
    This Diabetes Drug Saves Lives. You Can Thank The FDA Jun 13 2016
    Novo diabetes drug cuts heart risks by 13 pct in key trial Jun 13 2016
    Novo Slumps as Study on Victoza’s Heart Impact Disappoints Jun 13 2016
    Faster-acting insulin aspart showed a statistically significant reduction in HbA(1c) in type 1... Jun 13 2016
    Faster-acting insulin aspart showed a statistically significant reduction in HbA(1c) in type 1... Jun 13 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)